Advancis Pharmacautical enters marketing agreement with Innovex

Share this article:
Advancis Pharmaceutical Corporation has entered into a two-year sales and marketing agreement with Innovex for 75 sales reps to promote Advancis' recently approved cephalosporin antibiotic Keflex (cephalexin). Promotion of Keflex was scheduled to begin in mid-July.
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.